In Re the Dow Chemical Co

837 F.2d 469, 5 U.S.P.Q. 2d (BNA) 1529, 1988 U.S. App. LEXIS 587, 1988 WL 3589
CourtCourt of Appeals for the Federal Circuit
DecidedJanuary 25, 1988
Docket87-1406
StatusPublished
Cited by71 cases

This text of 837 F.2d 469 (In Re the Dow Chemical Co) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re the Dow Chemical Co, 837 F.2d 469, 5 U.S.P.Q. 2d (BNA) 1529, 1988 U.S. App. LEXIS 587, 1988 WL 3589 (Fed. Cir. 1988).

Opinion

PAULINE NEWMAN, Circuit Judge.

Dow Chemical Company appeals the decisions of the United States Patent and Trademark Office Board of Patent Appeals and Interferences, No. 86-3426 (Feb. 25, 1987) and No. 662-81 (Mar. 25, 1986), together rejecting all the claims on reexamination of United States Patent No. 3,919,-354 entitled “Impact Resistant Polymers of a Resinous Copolymer of an Alkenyl Aromatic Monomer and an Unsaturated Dicar-boxylic Anhydride.”. We reverse.

The Rejection

The invention is an impact resistant rubber-based resin having improved resistance to heat distortion. Claim 28, the broadest claim on appeal, is illustrative:

28. A polymer suitable for molding and extrusion, of substantially improved resistance to mechanical shock and impact, the polymer consisting essentially of the polymerization product of
a. a monovinyl alkenyl aromatic monomer containing up to 12 carbon atoms and having the alkenyl group attached directly to the benzene nucleus, the alkenyl aromatic compound being present in a proportion of from about 65 to 95 parts by weight and from 35 to 5 parts by weight of an unsaturated dicar-boxylic acid anhyride readily copolymer-izable therewith, and
b. from 5 to 35 parts by weight of a diene rubber per 100 parts of (a) plus (b), the rubber consisting essentially of 65 to 100 weight percent butadiene, or iso-prene and up to 35 weight percent of an alkenyl aromatic hydrocarbon as the sole other monomer in the rubber, the rubber having a glass temperature not higher than 0° C., the rubber being in the form of a plurality of particles having diameters within the range of 0.02 to 30 microns dispersed throughout a matrix of polymer of alkenyl aromatic monomer and the anhydride, at least a major portion of the rubber particles containing distinct occlusions of the polymer of (a), with the further limitation that
the polymer of (a) is a nonequimolar random copolymer.

*471 The preferred ingredients are styrene, ma-leic anhydride, and synthetic diene rubbers, and our discussion will be in these terms, as was the Board’s.

The Board’s decision that the claimed invention would have been obvious in terms of 35 U.S.C. § 103 was based on the combination of two references: a 1966 article by Molau and Keskkula entitled “Heterogeneous Polymer Systems IV. Mechanism of Rubber Particle Formation in Rubber-Modified Vinyl Polymers”, and Baer U.S. Patent No. 2,971,939. Also discussed were Farmer U.S. Patent No. 2,275,951 and a publication by Bacon and Farmer entitled “The Interaction of Maleic Anhydride with Rubber”, although the Board stated that the rejection was sustainable without relying on either of these references.

The Prior Art

The Molau/Keskkula article shows the preparation of a resin having high impact strength by dissolving synthetic diene rubber in styrene and polymerizing the styrene. This reference teaches that phase inversion is necessary to the formation of these moldable, extrudable resins. Baer prepares nonequimolar random maleic an-hydride-styrene copolymers by a technique whose salient feature is adding the maleic anhydride slowly to polymerizing styrene under controlled conditions.

Farmer shows the reaction among natural rubber, styrene, and maleic anhydride, and also states that maleic anhydride reacts directly with the rubber. The Bacon and Farmer article also shows the reaction of maleic anhydride with natural rubber. These products, according to Dow’s evidence and as found by the Board, do not have a dispersed rubber phase containing occlusions, and are not moldable.

Dow argues that the Board has engaged in hindsight reconstruction of the claimed invention. To support its position Dow refers to several scientific publications and other references, in addition to those cited by the PTO, and evidence submitted by declaration and deposition.

The first group of references to which Dow refers shows the reaction of maleic anhydride with natural or synthetic rubbers. These references show both intermolecular and intramolecular reactions between maleic anhydride and the various rubbers, but not a grafted rubber, which is said by Dow to characterize its product. Additional references are cited by Dow to show that maleic anhydride is much more reactive with diene-type synthetic rubbers than with natural rubber, and that the reaction with the synthetic rubbers is difficult to control and the product is unpredictable.

Another reference cited by Dow, the Encyclopedia of Science and Technology, states the general rule, derived from experience with acrylonitrile, that copolymers with synthetic diene rubbers have elevated glass transition temperatures; Dow advises that this is a highly undesirable property for a high-impact strength resin.

Another series of references cited by Dow shows several known techniques of reacting styrene and maleic anhydride to prepare nonequimolar copolymers, all different from the technique shown in the Baer patent.

Analysis

The Board held that the claimed product results from the application of the Baer technique to a styrene-maleic anhydride polymer system which includes synthetic diene rubber, and that it would have been obvious to do that which these inventors did if one wanted to increase the heat stability of a known high impact styrene rubber resin.

The crux of Dow’s argument is that no reference shows or suggests that these references should or could be combined successfully. Indeed, the Board agreed, stating that “[i]t is not apparent from the evidence whether rubber and maleic anhy-dride would have been expected to react in the process suggested by the combined disclosure of Molau and Baer_” (Emphasis in original).

Dow also points out, referring to the Keskkula evidence, that it was believed that these products could not be made by *472 the mass polymerization techniques of the prior art. Dow asserts that no reference, including Baer, suggested that the Baer technique could produce the requisite phase inversion in a system containing diene rubber, and could produce a diene-rubber containing resin that could be molded and had the other desired high-impact and thermal properties.

Dow refers to the Farmer patent, cited by the examiner and the Board, which shows that the reaction of styrene, maleic anhydride, and natural rubber forms a product that is unsuitable as a molding resin. Dow argues that Farmer leads away from the Dow invention, in that Farmer obtains precisely the “runaway” reaction, and undesirable product, that Keskkula believed was characteristic of reactions involving styrene, maleic anhydride, and rubbers. Dow points to Dr. Keskku-la’s Report to Dow management, written in 1966 at about the time the present invention was made, pointing out the many problems in attempting to produce the three-component product that these inventors later succeeded in producing.

In response, the Commissioner argues that even though an expert polymer scientist, Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Alam v. Andrew
S.D. Texas, 2020
Gray v. Berryhill
S.D. Texas, 2020
Harrison v. Saul
S.D. Texas, 2020
Bass v. Berryhill
S.D. Texas, 2020
Price v. Colvin
S.D. Texas, 2020
SANOFI v. Lupin Atl. Holdings S.A.
282 F. Supp. 3d 818 (D. Delaware, 2017)
Forest Laboratories, LLC v. Sigmapharm Laboratories, LLC
257 F. Supp. 3d 664 (D. Delaware, 2017)
Howmedica Osteonics Corp. v. Zimmer, Inc.
640 F. App'x 951 (Federal Circuit, 2016)
Santarus, Inc. v. Par Pharmaceutical, Inc.
694 F.3d 1344 (Federal Circuit, 2012)
In Re Applied Materials, Inc.
692 F.3d 1289 (Federal Circuit, 2012)
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.
876 F. Supp. 2d 295 (S.D. New York, 2012)
In Re Suong-Hyu Hyon
679 F.3d 1363 (Federal Circuit, 2012)
Alcon Research, Ltd. v. Apotex Inc.
790 F. Supp. 2d 868 (S.D. Indiana, 2011)
Pfizer v. Apotex (Formerly Known as Torpharm)
488 F.3d 1377 (Federal Circuit, 2007)
Pfizer, Inc. v. Apotex, Inc.
480 F.3d 1348 (Federal Circuit, 2007)
Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
482 F. Supp. 2d 390 (D. New Jersey, 2007)
Visto Corp. v. Sproqit Technologies, Inc.
413 F. Supp. 2d 1073 (N.D. California, 2006)
Boeing Co. v. United States
69 Fed. Cl. 397 (Federal Claims, 2005)
Eli Lilly & Co. v. Zenith Goldline Pharmaceuticals, Inc.
364 F. Supp. 2d 820 (S.D. Indiana, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
837 F.2d 469, 5 U.S.P.Q. 2d (BNA) 1529, 1988 U.S. App. LEXIS 587, 1988 WL 3589, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-the-dow-chemical-co-cafc-1988.